Search results
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA TODAY via Yahoo News· 6 days agoThe Centers for Disease Control and Prevention said it is tracking the new COVID variant KP.3 as data shows its dominance across the United States. “CDC is tracking SARS-& ...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 7 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, ...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines By Reuters
Investing.com· 4 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 3 days agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
Long COVID Risk Factors Revealed In Data From Nearly 5,000 People
IFLScience· 4 hours agoLong COVID describes a chronic condition that is present for at least three months after an...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 3 days agoIn March this year, the company reported positive interim immunogenicity data from the vaccine...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 5 days agoIn the study group of adults ages 50–64 years, the geometric mean ratios (GMRs) of mRNA-1083...
New COVID variant: What to know about KP.3
Newsweek· 5 days agoNicknamed "FLiRT," due to the positions of the mutations in their spike proteins, the new class of COVID subvariants has quickly spread through the U.S....
COMMENTARY: Misleading BMJ Public Health paper on COVID-19 excess mortality needs to be retracted
Center for Infectious Disease Research and Policy· 6 hours agoThe paper's results have been taken to mean that vaccines are dangerous, and this has led to...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 3 days agoCyanVac and its affiliate Blue Lake Biotechnology are developing the single-dose, intranasal vaccine...